[Pharmacological studies on N-benzoyl-N'-phenyl-2,6-diaminobenzoic acid (F-1). 1. Anti-inflammatory action].
D000311:Adrenal Glands / Q000032:analysis; D000632:Aminopyrine / Q000494:pharmacology; D000818:Animals; D000893:Anti-Inflammatory Agents; D001168:Arthritis / Q000188:drug therapy; D001205:Ascorbic Acid / Q000032:analysis; D001241:Aspirin / Q000494:pharmacology; D001565:Benzoates / Q000494:pharmacology*; D002199:Capillary Permeability / Q000187:drug effects; D055598:Chemical Phenomena; D002621:Chemistry; D004353:Drug Evaluation, Preclinical; D004487:Edema / Q000188:drug therapy; D004890:Erythema / Q000188:drug therapy; D005439:Flufenamic Acid / Q000494:pharmacology; D005753:Gastric Mucosa / Q000187:drug effects; D006099:Granuloma / Q000188:drug therapy; D008528:Mefenamic Acid / Q000494:pharmacology; D010653:Phenylbutazone / Q000494:pharmacology; D010655:Phenylenediamines / Q000494:pharmacology*; D011239:Prednisolone / Q000494:pharmacology; D051381:Rats; D013950:Thymus Gland / Q000187:drug effects
D000893:Anti-Inflammatory Agents; D001565:Benzoates; D010655:Phenylenediamines; D000632:Aminopyrine; D008528:Mefenamic Acid; D005439:Flufenamic Acid; D011239:Prednisolone; D010653:Phenylbutazone; D001205:Ascorbic Acid; D001241:Aspirin